For all the talk of msb on this thread the fact remains. They trade more than 30,000 volume and the retail market investors know they exist. Cynata is great buying at this level, but no one seems to care. I think we have seven years of ‘discussion fatigue’
- Forums
- ASX - By Stock
- CYP
- Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial, page-178
-
- There are more pages in this discussion • 318 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
25.0¢ |
Change
-0.010(3.85%) |
Mkt cap ! $44.90M |
Open | High | Low | Value | Volume |
26.0¢ | 26.5¢ | 25.0¢ | $5.869K | 22.42K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29342 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29342 | 0.250 |
2 | 31297 | 0.245 |
4 | 107225 | 0.240 |
1 | 100000 | 0.235 |
2 | 15173 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 30000 | 1 |
0.290 | 7125 | 3 |
0.295 | 183892 | 1 |
0.300 | 85000 | 2 |
0.310 | 16591 | 3 |
Last trade - 15.47pm 11/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
CXO
Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
CYP (ASX) Chart |